JW Pharmaceutical Inventory

The latest inventory for 001060.KS is $110B as of June 2026. That compares with $120B in the prior-year period — down 6.5% year over year. Investors often review this figure alongside JW Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 001060.KS's inventory moved from $120B to $110B — a 6.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in JW Pharmaceutical's operating scale or balance-sheet position.

A inventory figure of $110B for 001060.KS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 001060.KS's inventory ($110B), review year-over-year change from $120B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.